'Deadly Risk' of Fat-Loss Drugs
Newsweek US
|March 22, 2024
Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts
"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.
The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.
Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.
In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.
Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.
The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.
Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.
Denne historien er fra March 22, 2024-utgaven av Newsweek US.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Newsweek US
Newsweek US
From the Arctic to the Sahara, Extremes Put New Vehicles to the Test
BATTLE TESTED Mercedes-Benz GLB undergoes extreme conditions testing in Germany.
1 mins
December 26, 2025
Newsweek US
'IF HE GETS RID OF MADURO, WE'LL FORGIVE HIM'
Venezuelan exiles in a Miami suburb are backing Trump's efforts to remove the leader from power
4 mins
December 26, 2025
Newsweek US
BROOKS RETURNS TO FORM
The legendary director of movies including Terms of Endearment finds humor and heartache in Ella McCay
6 mins
December 26, 2025
Newsweek US
ERIKA ALEXANDER & KIM COLES
Erika Alexander and Kim Coles on their podcast ReLiving Single, the “limitless creativity” of Living Single and the sitcom’s enduring impact on pop culture
2 mins
December 26, 2025
Newsweek US
Behind Russia's Battle Lines
Exclusive images taken along the Russia-Ukraine frontier offer a first look inside Moscow's ranks
2 mins
December 26, 2025
Newsweek US
RISKY BUSINESS
As President Donald Trump weighs action against Venezuela's leader Nicolás Maduro, experts warn that intervention could trigger a violent, yearslong insurgency
10 mins
December 26, 2025
Newsweek US
'A CRISIS BEYOND OUR CONTROL'
Sri Lanka's President Anura Kumara Dissanayake urges global partners to help him make his country climate-proof, in an exclusive interview with Newsweek
5 mins
December 26, 2025
Newsweek US
General Motors Is Laser-Focused on F1 & Global Expansion
WHILE CHINESE CAR COMPANIES HAVE BEEN THE subject of most of the attention for their global expansion plans, one of America’s oldest automakers has similar ambitions.
3 mins
December 26, 2025
Newsweek US
WORLD'S MOST ANTICIPATED NEW VEHICLES 2026
Excitement is building for these autos, coming soon to global markets
3 mins
December 26, 2025
Newsweek US
PAUL FEIG
DIRECTOR PAUL FEIG WANTS YOU TO SUPPORT LOCAL MOVIE THEATERS, ideally at his new movie The Housemaid, based on the popular book series by Freida McFadden.
1 mins
December 26, 2025
Listen
Translate
Change font size

